The Daily Papule

Meeting abstracts

SID 2026

Society for Investigative Dermatology · Chicago, 13–16 May 2026

1,233 abstracts, published in JID on 21 July 2026. Their text is on the JID website.

  1. 0015

    Using the hidradenitis suppurativa skin organ culture model to assess mechanisms of action and efficacy in disease amelioration of FDA approved drugs

    Viola-Söhnlein J, Fehrholz M, … senior author Bertolini M

  2. 0024

    Single-cell and spatial analyses identify a TNFSF14-driven S100A8high monocyte–Th17–keratinocyte axis in early hidradenitis suppurativa

    Jiang R, Bogle R, … senior author Gudjonsson JE

  3. 0028

    Lineage-specific remodeling of resident-associated T cells in hidradenitis suppurativa

    Tang X, Wang B

  4. 0067

    Computational discovery of precision therapeutics for hidradenitis suppurativa

    Lee EY, Leboit P, … senior author Sirota M

  5. 0069

    Spatially resolved mucosal-like epithelial reprogramming linked to innate and adaptive immune activities in hidradenitis suppurativa tunnels

    Chu C, Lu CP

  6. 0088

    Spatial characterization of mast cells and nerve fibers in hidradenitis suppurativa using hybrid open-top light-sheet microscopy

    Meisenheimer J, Alley D, … senior author Goldfarb N

  7. 0095

    Identifying drug repurposing candidate for hidradenitis suppurativa using an integrated phenotype-to-mechanism framework

    Wang W, Zhou M, … senior author Su C

  8. 0104

    Integrative transcriptomic profiling identifies a dominant macrophage-derived IL-1β/NLRP3 inflammasome axis in hidradenitis suppurativa

    Shrotri S, Daamen A, … senior author Lipsky P

  9. 0107

    Spatial transcriptomics identifies GPR15LG-expressing keratinocytes in hidradenitis suppurativa tunnels

    Subramaniam H, Suresh A, … senior author Eisenstein A

  10. 0116

    Single-cell RNA-sequencing of PBMCs reveals systemic immune activation, metabolic rewiring, and regulatory disruption in hidradenitis suppurativa

    Reza M, Adrianto I, … senior author Mi Q

  11. 0132

    Novel human organotypic model of hidradenitis suppurativa tunnel recapitulates disease wound healing phenotype

    Nagalla RR, Prajapati T, … senior author Pastar I

  12. 0159

    High resolution spatial profiling of hidradenitis suppurativa reveals spatial interactions in key fibroblast subtypes

    Zhang H, Cai Y, … senior author Tsoi L

  13. 0183

    Hidradenitis suppurativa and inflammatory bowel disease: A single-center retrospective study

    Cutrona M, Koseki M, … senior author Cices A

  14. 0187

    Geospatial associations of environmental toxicants with hidradenitis suppurativa

    McCaffrey T, Badiei B, … senior author Garza LA

  15. 0188

    Association of hidradenitis suppurativa with eating disorders: A retrospective TriNetX study

    Chung CS, Kherallah K, … senior author Lee KH

  16. 0201

    Impact of biologic therapy on emergency department utilization in pediatric hidradenitis suppurativa patients: A TriNetX study

    Kherallah K, Chung CS, … senior author Lee KH

  17. 0221

    Impact of GLP-1 receptor agonists on the risk of inflammatory arthropathies in patients with hidradenitis suppurativa: A population-based cohort study

    Ure A, Aflatooni S, … senior author Armstrong AW

  18. 0231

    Association between hidradenitis suppurativa and gastrointestinal comorbidities

    Chen J, Eichenfield L, Eichenfield D

  19. 0233

    No-show patterns among patients with hidradenitis suppurativa at a rural tertiary center

    Hernandez N, Ollila N, … senior author Fragoso N

  20. 0240

    Mammography among patients with hidradenitis suppurativa

    Katamanin O, Hailemichael R, … senior author Flood K

  21. 0252

    A geospatial analysis of neighborhood air pollution and hidradenitis suppurativa

    McCaffrey T, Badiei B, … senior author Garza LA

  22. 0270

    Therapeutic drug monitoring of infliximab in hidradenitis suppurativa

    Young A, Zhan X, … senior author Mi Q

  23. 0271

    Elevated risk of postpartum wound complications in hidradenitis suppurativa patients following cesarean delivery

    Sidhu KS, Powers E, … senior author Ashack K

  24. 0272

    Determinants of infliximab drug survival in hidradenitis suppurativa

    Young A, Zhan X, … senior author Mi Q

  25. 0278

    Rising emergency department utilization suggests a true increase in hidradenitis suppurativa incidence beyond diagnostic awareness

    Elghannam M, McCaffrey T, … senior author Garza LA

  26. 0284

    Evaluating the association between adalimumab use in hidradenitis suppurativa patients and psoriasiform events: A retrospective cohort study

    Park JH, Ramos-Briceño DA, … senior author Kaunitz G

  27. 0290

    Association of hidradenitis suppurativa with risk of diabetic foot ulcer in patients with type 2 diabetes

    Nguyen M, Kapur S, … senior author Burkhart C

  28. 0303

    Buprenorphine use for chronic pain management in patients with hidradenitis suppurativa

    Ohamadike C, Adekunle T, … senior author Orenstein LA

  29. 0316

    Patterns of medical and surgical therapy for hidradenitis suppurativa in rural new england

    Chan B, Hernandez N, … senior author Fragoso N

  30. 0321

    Genetic evidence implicates metabolic dysfunction as a driver of hidradenitis suppurativa: A bidirectional Mendelian randomization study

    Casagrande M, Ramessur RR, … senior author Petukhova L

  31. 0339

    Limitations of hurley staging in assessing response to GLP-1 therapy in hidradenitis suppurativa

    Von Lotten M, Collins C, … senior author Kole L

  32. 0346

    Surgical outcomes for hidradenitis suppurativa: Does biologic therapy make a difference?

    Kann R, Weitzner Y, … senior author Ciocon D

  33. 0348

    Depression screening tools in hidradenitis suppurativa: A scoping review of clinical and research practices

    Yan MJ, Jiang YC, … senior author Chen S

  34. 0356

    Quantifying drug-associated and drug-worsened hidradenitis suppurativa using FAERS (2003–2023)

    Maas K, Brewer C, … senior author Mukherjee EM

  35. 0367

    Hidradenitis suppurativa and HS-like cutaneous adverse events associated with γ-secretase inhibitors

    McCaffrey T, Li A, … senior author Garza LA

  36. 0370

    Reduced sleep efficiency and REM sleep in hidradenitis suppurativa: Evidence from wearable-derived biometric data

    Aflatooni S, Johnsen NA, … senior author Armstrong AW

  37. 0375

    Increased risk of deep vein thrombosis and pulmonary embolism in hidradenitis suppurativa patients with Down syndrome: A retrospective cohort study

    Chung CS, Kherallah K, … senior author Hsiao JL

  38. 0387

    Early-onset hidradenitis suppurativa elevates infection risk

    Lee T, Kapur S, … senior author Burkhart C

  39. 0397

    Metabolic multimorbidity in hidradenitis suppurativa: A cross-sectional survey of US adults

    Delgado J, Scrimshaw E, … senior author Petukhova L

  40. 0406

    Risk factors of new-onset depression in hidradenitis suppurativa: A retrospective chart review at a rural tertiary center

    Zhu H, Alberto N, … senior author Sahmoun A

  41. 0423

    Shared systemic risks among patients with hidradenitis suppurativa and lichen sclerosus

    Bova E, Sidhu KS, … senior author Burkhart C

  42. 0450

    Vitamin D impact on inflammatory pathways in hidradenitis suppurativa

    Trenholm IM, Do HK, … senior author Cohen SR

  43. 0453

    Characterization and optimization of hidradenitis suppurativa in an elderly cohort

    Trenholm IM, Do HK, … senior author Cohen SR

  44. 0454

    Geographic clustering and climate-associated severity of hidradenitis suppurativa in a large urban cohort

    Tan IJ, Do HK, … senior author Cohen SR

  45. 0456

    Regional and structural treatment variation in hidradenitis suppurativa: A national Epic Cosmos analysis

    Barnes LA, Yeh S, … senior author Moskatel L

  46. 0473

    The emerging role of ertapenem in recalcitrant hidradenitis suppurativa: A systematic review

    Gurram A, Park JH, … senior author Gonzalez AM

  47. 0496

    The immunometabolic effects of glucagon-like peptide-1 receptor agonists in psoriasis and hidradenitis suppurativa

    Morales JK, Cotter DG

  48. 0507

    A pilot study evaluating preliminary efficacy of deucravacitinib compared to placebo in the treatment of moderate-to-severe hidradenitis suppurativa (HS)

    Tehrani MD, Porter ML, … senior author Kimball AB

  49. 0520

    Ultrasound-guided sclerotherapy for tunnels in hidradenitis suppurativa integrating imaging-based phenotype classification

    Khatib-Shahidi B, Sidhu KS, … senior author Ashack K

  50. 0548

    Assessing the relationship between vitamin D levels and risk of major adverse cardiovascular and thromboembolic events in patients with hidradenitis suppurativa

    Ramos-Briceño DA, Park JH, … senior author Gonzalez AM